However, in contrast to inflammatory and clinical parameters, initiation of MTX or MTX combined with an TNFi in RA and PsA patients and TNFi monotherapy in AS patients, was not related to reduction in circulating levels of NT-proBNP during our 6-month follow-up study. The gene discussed is NPPB; the disease is rheumatoid arthritis.